Aathira Ravindranath, Anshu Srivastava, Surender K. Yachha, Ujjal Poddar, Moinak S. Sarma, Amrita Mathias
{"title":"住院慢性肝病儿童肝性脑病的发病率和诱因","authors":"Aathira Ravindranath, Anshu Srivastava, Surender K. Yachha, Ujjal Poddar, Moinak S. Sarma, Amrita Mathias","doi":"10.1016/j.jceh.2024.101452","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>Hepatic encephalopathy (HE) is a marker of poor prognosis in adults with chronic liver disease (CLD). We prospectively studied the prevalence and precipitants of HE in children with CLD as there is a paucity of literature on the same.</p></div><div><h3>Methods</h3><p>Children (1–18 years) admitted with CLD were examined daily for the presence and grading of HE (West Haven/Whittington grading). Precipitants were classified as infection, dyselectrolytemia, gastrointestinal bleeding, constipation and dehydration. Changes in grades of HE and outcome were noted.</p></div><div><h3>Results</h3><p>One hundred and sixty children (age 120 [84–168] months) were enrolled. HE was present in 50 (31.2%) patients with a total of 61 episodes. Maximum grade of HE was grade I (n = 16), II (n = 23), III (n = 11) and IV (n = 11). Forty-two cases had single and 8 had recurrent (2–5) episodes. Median duration of HE episodes was 96 (72–192) hours. Precipitants were identified in 55/61 (90.2%) episodes with infection (45/61, 73.7%) and dyselectrolytemia (33/61, 54%) being the most common. Lower albumin and sodium, higher INR and presence of infection were significantly associated with presence of HE. Overall, HE resolved in 33 (54%) episodes, while it progressed and persisted in 28 (45.9%) episodes. Patients with HE had a poorer outcome (25/50 vs 13/110; <em>P</em> < 0.01) with both higher in-hospital (11/50 vs 9/110; <em>P</em> = 0.02) and 1-month post discharge (14/39 vs 4/101; <em>P</em> < 0.01) mortality than those without HE.</p></div><div><h3>Conclusion</h3><p>One-third of admitted CLD children have HE, with identifiable precipitants in 90% of cases. Children with HE have poorer liver functions, higher rate of infections and worse outcome than those without HE.</p></div>","PeriodicalId":15479,"journal":{"name":"Journal of Clinical and Experimental Hepatology","volume":"14 6","pages":"Article 101452"},"PeriodicalIF":3.3000,"publicationDate":"2024-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Prevalence and Precipitants of Hepatic Encephalopathy in Hospitalized Children With Chronic Liver Disease\",\"authors\":\"Aathira Ravindranath, Anshu Srivastava, Surender K. Yachha, Ujjal Poddar, Moinak S. Sarma, Amrita Mathias\",\"doi\":\"10.1016/j.jceh.2024.101452\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><p>Hepatic encephalopathy (HE) is a marker of poor prognosis in adults with chronic liver disease (CLD). We prospectively studied the prevalence and precipitants of HE in children with CLD as there is a paucity of literature on the same.</p></div><div><h3>Methods</h3><p>Children (1–18 years) admitted with CLD were examined daily for the presence and grading of HE (West Haven/Whittington grading). Precipitants were classified as infection, dyselectrolytemia, gastrointestinal bleeding, constipation and dehydration. Changes in grades of HE and outcome were noted.</p></div><div><h3>Results</h3><p>One hundred and sixty children (age 120 [84–168] months) were enrolled. HE was present in 50 (31.2%) patients with a total of 61 episodes. Maximum grade of HE was grade I (n = 16), II (n = 23), III (n = 11) and IV (n = 11). Forty-two cases had single and 8 had recurrent (2–5) episodes. Median duration of HE episodes was 96 (72–192) hours. Precipitants were identified in 55/61 (90.2%) episodes with infection (45/61, 73.7%) and dyselectrolytemia (33/61, 54%) being the most common. Lower albumin and sodium, higher INR and presence of infection were significantly associated with presence of HE. Overall, HE resolved in 33 (54%) episodes, while it progressed and persisted in 28 (45.9%) episodes. Patients with HE had a poorer outcome (25/50 vs 13/110; <em>P</em> < 0.01) with both higher in-hospital (11/50 vs 9/110; <em>P</em> = 0.02) and 1-month post discharge (14/39 vs 4/101; <em>P</em> < 0.01) mortality than those without HE.</p></div><div><h3>Conclusion</h3><p>One-third of admitted CLD children have HE, with identifiable precipitants in 90% of cases. Children with HE have poorer liver functions, higher rate of infections and worse outcome than those without HE.</p></div>\",\"PeriodicalId\":15479,\"journal\":{\"name\":\"Journal of Clinical and Experimental Hepatology\",\"volume\":\"14 6\",\"pages\":\"Article 101452\"},\"PeriodicalIF\":3.3000,\"publicationDate\":\"2024-05-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Clinical and Experimental Hepatology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0973688324001099\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical and Experimental Hepatology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0973688324001099","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
目的肝性脑病(HE)是成人慢性肝病(CLD)患者预后不良的标志。由于相关文献较少,我们对 CLD 儿童肝性脑病的发病率和诱因进行了前瞻性研究。方法每天对收治的 CLD 儿童(1-18 岁)进行检查,以确定是否存在肝性脑病并对其进行分级(West Haven/Whittington 分级)。诱发因素分为感染、双选择性溶血、消化道出血、便秘和脱水。结果 有 160 名儿童(年龄 120 [84-168] 个月)参加了研究。有 50 名儿童(31.2%)出现肠梗阻,共发作 61 次。HE 的最高级别为 I 级(16 例)、II 级(23 例)、III 级(11 例)和 IV 级(11 例)。42例为单发,8例为复发(2-5次)。高血压发作的中位持续时间为 96(72-192)小时。55/61(90.2%)次病例的诱发因素被确定,其中最常见的是感染(45/61,73.7%)和二选择性溶血(33/61,54%)。白蛋白和钠较低、INR较高和感染与 HE 的出现有显著相关性。总体而言,33 例(54%)血栓栓塞缓解,28 例(45.9%)血栓栓塞进展和持续。HE 患者的预后较差(25/50 vs 13/110; P < 0.01),院内死亡率(11/50 vs 9/110; P = 0.02)和出院后 1 个月死亡率(14/39 vs 4/101; P < 0.01)均高于无 HE 患者。与无 HE 的儿童相比,有 HE 的儿童肝功能较差,感染率较高,预后较差。
Prevalence and Precipitants of Hepatic Encephalopathy in Hospitalized Children With Chronic Liver Disease
Objective
Hepatic encephalopathy (HE) is a marker of poor prognosis in adults with chronic liver disease (CLD). We prospectively studied the prevalence and precipitants of HE in children with CLD as there is a paucity of literature on the same.
Methods
Children (1–18 years) admitted with CLD were examined daily for the presence and grading of HE (West Haven/Whittington grading). Precipitants were classified as infection, dyselectrolytemia, gastrointestinal bleeding, constipation and dehydration. Changes in grades of HE and outcome were noted.
Results
One hundred and sixty children (age 120 [84–168] months) were enrolled. HE was present in 50 (31.2%) patients with a total of 61 episodes. Maximum grade of HE was grade I (n = 16), II (n = 23), III (n = 11) and IV (n = 11). Forty-two cases had single and 8 had recurrent (2–5) episodes. Median duration of HE episodes was 96 (72–192) hours. Precipitants were identified in 55/61 (90.2%) episodes with infection (45/61, 73.7%) and dyselectrolytemia (33/61, 54%) being the most common. Lower albumin and sodium, higher INR and presence of infection were significantly associated with presence of HE. Overall, HE resolved in 33 (54%) episodes, while it progressed and persisted in 28 (45.9%) episodes. Patients with HE had a poorer outcome (25/50 vs 13/110; P < 0.01) with both higher in-hospital (11/50 vs 9/110; P = 0.02) and 1-month post discharge (14/39 vs 4/101; P < 0.01) mortality than those without HE.
Conclusion
One-third of admitted CLD children have HE, with identifiable precipitants in 90% of cases. Children with HE have poorer liver functions, higher rate of infections and worse outcome than those without HE.